Kathy Boltz, PhD

Most Recent Articles by Kathy Boltz, PhD

Programs for Lay Health Advisors Can Be Designed to Maximize Their Impact

Clear role expectations and organization support are vital for lay health advisors.

Nivolumab Shows Promise Against Aggressive Anal Cancer

Clinical trial results are promising for the use of nivolumab to treat squamous cell carcinoma of the anal canal, according to data presented at the 2016 American Association for Cancer Research Annual Meeting.

Targeting Drugs to Pancreatic Cancer Through Implantable Device

New research indicates a far greater efficacy in pancreatic cancer drug therapy delivered via implantable device than via IV.

Targeted Therapy Enhances Chemotherapy, Improves Outcomes in Retinoblastoma

The effectiveness of chemotherapy was enhanced by targeting survivin, a protein that inhibits apoptosis or cell death, according to preclinical research in cells and mouse models of retinoblastoma.

Early Study Results Show Guadecitabine Effective for Metastatic Colorectal Cancer

A small, phase I clinical trial indicates the experimental drug guadecitabine is safe in combination with the chemotherapy drug irinotecan, and it may overcome resistance to irinotecan in patients with metastatic colorectal cancer.

More Articles by Kathy Boltz, PhD

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs